Metabolomic analysis reveals metabolic disturbances in the prefrontal cortex of the lipopolysaccharide-induced mouse model of depression
Authors:
- 1 July 2016
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 308, 115-127
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviorsJournal of Neuroinflammation, 2013
- Metabolomic Analysis Reveals Metabolic Disturbance in the Cortex and Hippocampus of Subchronic MK-801 Treated RatsPLOS ONE, 2013
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- The GABAergic deficit hypothesis of major depressive disorderMolecular Psychiatry, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortexBehavioural Brain Research, 2009
- Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like BehaviorsBiological Psychiatry, 2008
- Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedoniaJournal of Neuroinflammation, 2008
- Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in miceMolecular Psychiatry, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008